Literature DB >> 35154601

Identification of key candidate genes and pathways associated with colorectal aberrant crypt foci-to-adenoma-to-carcinoma progression.

Setareh Fayazfar1, Afsaneh Arefi Oskouie2, Akram Safaei1,2, Hakimeh Zali3, Ehsan Nazemalhosseini Mojarad4.   

Abstract

AIM: The present study aimed to detect key candidate genes and pathways involved in colorectal aberrant crypt foci-to-adenoma-to-carcinoma progression.
BACKGROUND: Although colorectal cancer (CRC) is the third most common type of cancer, the involved signaling pathways and driver-genes remain largely unclear. CRC begins with the malignant transformation of precancerous lesions including aberrant crypt foci (ACF) and benign adenomatous polyp or adenoma.
METHODS: A list of formerly reported ACF, adenoma, and CRC-associated proteins was obtained from GeneCards, and then the data in online David Bioinformatics Resources was analyzed. The protein-protein interactions were surveyed utilizing String database and Cytoscape software. After hubs and bottlenecks were recognized, the key genes and pathways were identified through different bioinformatics analysis.
RESULTS: The most important pathways associated with colorectal aberrant crypt foci-to-adenoma progression were attributed to "pathways in cancer" and "chemokine signaling pathway" and those in adenoma-to-carcinoma progression were related to "pathways in cancer," "chemokine signaling pathway," and "Ras signaling pathway." The genes participating in these pathways are key ones. Furthermore, PRKACB, CUL2, and GSK3B were significant as the seed in the clusters related to adenoma and GNB1, RALBP1, ROCK1, and IKBKG in the clusters related to cancer.
CONCLUSION: The key candidate genes and pathways in progress CRC formed precursor lesions were identified by integrated bioinformatics analysis. The results could lead to a better understanding of the cause and underlying molecular events as well as detection of therapeutic targets for CRC. ©2021 RIGLD, Research Institute for Gastroenterology and Liver Diseases.

Entities:  

Keywords:  Aberrant crypt foci; Adenomatous polyp; Colorectal cancer; Key genes and pathways

Year:  2021        PMID: 35154601      PMCID: PMC8817750     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol Bed Bench        ISSN: 2008-2258


  49 in total

1.  Colorectal cancer in patients under close colonoscopic surveillance.

Authors:  Douglas J Robertson; E Robert Greenberg; Michael Beach; Robert S Sandler; Dennis Ahnen; Robert W Haile; Carol A Burke; Dale C Snover; Robert S Bresalier; Gail McKeown-Eyssen; Jack S Mandel; John H Bond; Rosalind U Van Stolk; Robert W Summers; Richard Rothstein; Timothy R Church; Bernard F Cole; Tim Byers; Leila Mott; John A Baron
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

Review 2.  Role of aberrant crypt foci in understanding the pathogenesis of colon cancer.

Authors:  R P Bird
Journal:  Cancer Lett       Date:  1995-06-29       Impact factor: 8.679

3.  Aberrant crypt foci of the colon as precursors of adenoma and cancer.

Authors:  T Takayama; S Katsuki; Y Takahashi; M Ohi; S Nojiri; S Sakamaki; J Kato; K Kogawa; H Miyake; Y Niitsu
Journal:  N Engl J Med       Date:  1998-10-29       Impact factor: 91.245

4.  Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.

Authors:  Yan-Lei Ma; Jia-Yuan Peng; Peng Zhang; Long Huang; Wei-Jie Liu; Tong-Yi Shen; Hong-Qi Chen; Yu-Kun Zhou; Ming Zhang; Zhao-Xin Chu; Huan-Long Qin
Journal:  J Proteome Res       Date:  2009-10       Impact factor: 4.466

Review 5.  Targeting RAS signalling pathways in cancer therapy.

Authors:  Julian Downward
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

6.  Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.

Authors:  Beatriz Carvalho; Anke H Sillars-Hardebol; Cindy Postma; Sandra Mongera; Jochim Terhaar Sive Droste; Askar Obulkasim; Mark van de Wiel; Wim van Criekinge; Bauke Ylstra; Remond J A Fijneman; Gerrit A Meijer
Journal:  Cell Oncol (Dordr)       Date:  2012-01-26       Impact factor: 6.730

7.  STRING 8--a global view on proteins and their functional interactions in 630 organisms.

Authors:  Lars J Jensen; Michael Kuhn; Manuel Stark; Samuel Chaffron; Chris Creevey; Jean Muller; Tobias Doerks; Philippe Julien; Alexander Roth; Milan Simonovic; Peer Bork; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2008-10-21       Impact factor: 16.971

8.  Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations.

Authors:  George Emmanouil; George Ayiomamitis; Adamantia Zizi-Sermpetzoglou; Maria Tzardi; Andrew Moursellas; Argyro Voumvouraki; Elias Kouroumalis
Journal:  Anal Cell Pathol (Amst)       Date:  2018-04-16       Impact factor: 2.916

9.  Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.

Authors:  Isabel Quintanilla; María López-Cerón; Mireya Jimeno; Miriam Cuatrecasas; Michel Zabalza; Leticia Moreira; Virginia Alonso; Cristina Rodríguez de Miguel; Jennifer Muñoz; Sergi Castellvi-Bel; Josep Llach; Antoni Castells; Francesc Balaguer; Jordi Camps; Maria Pellisé
Journal:  Clin Transl Gastroenterol       Date:  2019-06       Impact factor: 4.488

Review 10.  Clinical implications of BRAF mutation test in colorectal cancer.

Authors:  Ehsan Nazemalhosseini Mojarad; Roya Kishani Farahani; Mahdi Montazer Haghighi; Hamid Asadzadeh Aghdaei; Peter Jk Kuppen; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.